Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Mathematical models used to inform study design or surveillance systems in infectious diseases: a systematic review

Authors: Sereina A. Herzog, Stéphanie Blaizot, Niel Hens

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Mathematical models offer the possibility to investigate the infectious disease dynamics over time and may help in informing design of studies. A systematic review was performed in order to determine to what extent mathematical models have been incorporated into the process of planning studies and hence inform study design for infectious diseases transmitted between humans and/or animals.

Methods

We searched Ovid Medline and two trial registry platforms (Cochrane, WHO) using search terms related to infection, mathematical model, and study design from the earliest dates to October 2016. Eligible publications and registered trials included mathematical models (compartmental, individual-based, or Markov) which were described and used to inform the design of infectious disease studies. We extracted information about the investigated infection, population, model characteristics, and study design.

Results

We identified 28 unique publications but no registered trials. Focusing on compartmental and individual-based models we found 12 observational/surveillance studies and 11 clinical trials. Infections studied were equally animal and human infectious diseases for the observational/surveillance studies, while all but one between humans for clinical trials. The mathematical models were used to inform, amongst other things, the required sample size (n = 16), the statistical power (n = 9), the frequency at which samples should be taken (n = 6), and from whom (n = 6).

Conclusions

Despite the fact that mathematical models have been advocated to be used at the planning stage of studies or surveillance systems, they are used scarcely. With only one exception, the publications described theoretical studies, hence, not being utilised in real studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. Research for universal health coverage. Geneva, Switzerland: World Health Organization; 2013. World Health Organization. Research for universal health coverage. Geneva, Switzerland: World Health Organization; 2013.
2.
go back to reference Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, New York: Oxford University Press; 1991. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, New York: Oxford University Press; 1991.
3.
go back to reference Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press; 2008. Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press; 2008.
4.
go back to reference Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347:aaa4339. doi: 10.1126/science.aaa4339. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347:aaa4339. doi: 10.​1126/​science.​aaa4339.
6.
go back to reference Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, Beutels P. Modeling infectious disease parameters based on serological and social contact data: a modern statistical perspective. New York: Springer; 2012.CrossRef Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, Beutels P. Modeling infectious disease parameters based on serological and social contact data: a modern statistical perspective. New York: Springer; 2012.CrossRef
8.
go back to reference Buckeridge DL, Burkom H, Moore A, Pavlin J, Cutchis P, Hogan W. Evaluation of syndromic surveillance systems--design of an epidemic simulation model. MMWR supplements. 2004;53:137–43.PubMed Buckeridge DL, Burkom H, Moore A, Pavlin J, Cutchis P, Hogan W. Evaluation of syndromic surveillance systems--design of an epidemic simulation model. MMWR supplements. 2004;53:137–43.PubMed
9.
go back to reference Cauchemez S, Boelle PY, Thomas G, Valleron AJ. Estimating in real time the efficacy of measures to control emerging communicable diseases. Am J Epidemiol. 2006;164:591–7.CrossRefPubMed Cauchemez S, Boelle PY, Thomas G, Valleron AJ. Estimating in real time the efficacy of measures to control emerging communicable diseases. Am J Epidemiol. 2006;164:591–7.CrossRefPubMed
10.
go back to reference Boily MC, Masse B, Alsallaq R, Padian NS, Eaton JW, Vesga JF, Hallett TB. HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med. 2012;9:e1001250.CrossRefPubMedPubMedCentral Boily MC, Masse B, Alsallaq R, Padian NS, Eaton JW, Vesga JF, Hallett TB. HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med. 2012;9:e1001250.CrossRefPubMedPubMedCentral
11.
go back to reference Koopman JS, Jacquez G, Chick SE. New data and tools for integrating discrete and continuous population modeling strategies. Ann N Y Acad Sci. 2001;954:268–94.CrossRefPubMed Koopman JS, Jacquez G, Chick SE. New data and tools for integrating discrete and continuous population modeling strategies. Ann N Y Acad Sci. 2001;954:268–94.CrossRefPubMed
12.
go back to reference Michael E, Malecela-Lazaro MN, Kazura JW. Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. Adv Parasit. 2007;65:191–237.CrossRef Michael E, Malecela-Lazaro MN, Kazura JW. Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. Adv Parasit. 2007;65:191–237.CrossRef
13.
go back to reference Restif O, Hayman DT, Pulliam JR, Plowright RK, George DB, Luis AD, et al. Model-guided fieldwork: practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics. Ecol Lett. 2012;15:1083–94.CrossRefPubMedPubMedCentral Restif O, Hayman DT, Pulliam JR, Plowright RK, George DB, Luis AD, et al. Model-guided fieldwork: practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics. Ecol Lett. 2012;15:1083–94.CrossRefPubMedPubMedCentral
14.
go back to reference Vynnycky E, White R. An introduction to disease modelling. Oxford: Oxford University Press; 2010. Vynnycky E, White R. An introduction to disease modelling. Oxford: Oxford University Press; 2010.
15.
go back to reference Sonnenberg FA, Gregory P, Yomtovian R, Russell LB, Tierney W, Kosmin M, Carson JL. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion. 1999;39:808–17.CrossRefPubMed Sonnenberg FA, Gregory P, Yomtovian R, Russell LB, Tierney W, Kosmin M, Carson JL. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion. 1999;39:808–17.CrossRefPubMed
16.
go back to reference Graat EA, de Jong MC, Frankena K, Franken P. Modelling the effect of surveillance programmes on spread of bovine herpesvirus 1 between certified cattle herds. Vet Microbiol. 2001;79:193–208.CrossRefPubMed Graat EA, de Jong MC, Frankena K, Franken P. Modelling the effect of surveillance programmes on spread of bovine herpesvirus 1 between certified cattle herds. Vet Microbiol. 2001;79:193–208.CrossRefPubMed
17.
go back to reference Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 2006;22:529–35.CrossRefPubMed Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 2006;22:529–35.CrossRefPubMed
18.
go back to reference Savill NJ, St Rose SG, Woolhouse ME. Detection of mortality clusters associated with highly pathogenic avian influenza in poultry: a theoretical analysis. J R Soc Interface. 2008;5:1409–19.CrossRefPubMedPubMedCentral Savill NJ, St Rose SG, Woolhouse ME. Detection of mortality clusters associated with highly pathogenic avian influenza in poultry: a theoretical analysis. J R Soc Interface. 2008;5:1409–19.CrossRefPubMedPubMedCentral
19.
go back to reference Arnold ME, Irvine RM, Tearne O, Rae D, Cook AJ, Breed AC. Investigation into sampling strategies in response to potential outbreaks of low pathogenicity notifiable avian influenza initiated in commercial duck holdings in great Britain. Epidemiol Infect. 2013;141:751–62.CrossRefPubMed Arnold ME, Irvine RM, Tearne O, Rae D, Cook AJ, Breed AC. Investigation into sampling strategies in response to potential outbreaks of low pathogenicity notifiable avian influenza initiated in commercial duck holdings in great Britain. Epidemiol Infect. 2013;141:751–62.CrossRefPubMed
21.
go back to reference Ciccolini M, Donker T, Grundmann H, Bonten MJ, Woolhouse ME. Efficient surveillance for healthcare-associated infections spreading between hospitals. P Natl Acad Sci USA. 2014;111:2271–6.CrossRef Ciccolini M, Donker T, Grundmann H, Bonten MJ, Woolhouse ME. Efficient surveillance for healthcare-associated infections spreading between hospitals. P Natl Acad Sci USA. 2014;111:2271–6.CrossRef
22.
go back to reference Gonzales JL, Boender GJ, Elbers AR, Stegeman JA, de Koeijer AA. Risk based surveillance for early detection of low pathogenic avian influenza outbreaks in layer chickens. Prev Vet Med. 2014;117:251–9.CrossRefPubMed Gonzales JL, Boender GJ, Elbers AR, Stegeman JA, de Koeijer AA. Risk based surveillance for early detection of low pathogenic avian influenza outbreaks in layer chickens. Prev Vet Med. 2014;117:251–9.CrossRefPubMed
23.
go back to reference Leslie E, Cowled B, Graeme Garner M, Toribio JA, Ward MP. Effective surveillance strategies following a potential classical swine fever incursion in a remote wild pig population in North-Western Australia. Transbound Emerg Dis. 2014;61:432–42.CrossRefPubMed Leslie E, Cowled B, Graeme Garner M, Toribio JA, Ward MP. Effective surveillance strategies following a potential classical swine fever incursion in a remote wild pig population in North-Western Australia. Transbound Emerg Dis. 2014;61:432–42.CrossRefPubMed
24.
go back to reference Mizumoto K, Ejima K, Yamamoto T, Nishiura H. On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling. J Vector Dis. 2014;51:153–64. Mizumoto K, Ejima K, Yamamoto T, Nishiura H. On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling. J Vector Dis. 2014;51:153–64.
25.
go back to reference Pinsent A, Blake IM, White MT, Riley S. Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time. BMC Infect Dis. 2014;14:427.CrossRefPubMedPubMedCentral Pinsent A, Blake IM, White MT, Riley S. Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time. BMC Infect Dis. 2014;14:427.CrossRefPubMedPubMedCentral
26.
go back to reference van Bunnik BAD, Ciccolini M, Gibbons CL, Edwards G, Fitzgerald R, McAdam PR, et al. Efficient national surveillance for health-care-associated infections. BMC Public Health. 2015;15:832.CrossRefPubMedPubMedCentral van Bunnik BAD, Ciccolini M, Gibbons CL, Edwards G, Fitzgerald R, McAdam PR, et al. Efficient national surveillance for health-care-associated infections. BMC Public Health. 2015;15:832.CrossRefPubMedPubMedCentral
28.
go back to reference Atlas RS, DuPont HL, Overall JE. Computer simulation of alternative sampling strategies to estimate risk of infection from cryptosporidium. Comput Biol Med. 1993;23:283–94. Atlas RS, DuPont HL, Overall JE. Computer simulation of alternative sampling strategies to estimate risk of infection from cryptosporidium. Comput Biol Med. 1993;23:283–94.
29.
go back to reference Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus Pneumoniae. Clin Infect Dis. 2001;32:1044–54.CrossRefPubMed Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus Pneumoniae. Clin Infect Dis. 2001;32:1044–54.CrossRefPubMed
31.
go back to reference Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C. Silico design of clinical trials: a method coming of age. Crit Care Med. 2004;32:2061–70.CrossRefPubMed Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C. Silico design of clinical trials: a method coming of age. Crit Care Med. 2004;32:2061–70.CrossRefPubMed
32.
go back to reference Hallett TB, Garnett GP, Mupamberiyi Z, Gregson S. Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol. 2008;37:77–87.CrossRefPubMed Hallett TB, Garnett GP, Mupamberiyi Z, Gregson S. Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol. 2008;37:77–87.CrossRefPubMed
33.
go back to reference Dimitrov DT, Masse BR, Boily MC. Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound. J Acq Immun Def Synd. 2013;62:95–101.CrossRef Dimitrov DT, Masse BR, Boily MC. Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound. J Acq Immun Def Synd. 2013;62:95–101.CrossRef
34.
go back to reference Nishiura H, Yen H, Cowling BJ. Sample size considerations for one-to-one animal transmission studies of the influenza a viruses. PLoS One. 2013;8:e55358.CrossRefPubMedPubMedCentral Nishiura H, Yen H, Cowling BJ. Sample size considerations for one-to-one animal transmission studies of the influenza a viruses. PLoS One. 2013;8:e55358.CrossRefPubMedPubMedCentral
35.
go back to reference Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9:e84511.CrossRefPubMedPubMedCentral Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9:e84511.CrossRefPubMedPubMedCentral
36.
go back to reference Cuadros DF, Abu-Raddad LJ, Awad SF, Garcia-Ramos G. Use of agent-based simulations to design and interpret HIV clinical trials. Comput Biol Med. 2014;50:1–8.CrossRefPubMed Cuadros DF, Abu-Raddad LJ, Awad SF, Garcia-Ramos G. Use of agent-based simulations to design and interpret HIV clinical trials. Comput Biol Med. 2014;50:1–8.CrossRefPubMed
37.
go back to reference Scott P, Herzog SA, Auranen K, Dagan R, Low N, Egger M, Heijne JCM. Timing of bacterial carriage sampling in vaccine trials: a modelling study. Epidemics. 2014;9:8–17.CrossRefPubMed Scott P, Herzog SA, Auranen K, Dagan R, Low N, Egger M, Heijne JCM. Timing of bacterial carriage sampling in vaccine trials: a modelling study. Epidemics. 2014;9:8–17.CrossRefPubMed
38.
go back to reference Herzog SA, Low N, Berghold A. Sample size considerations using mathematical models: an example with Chlamydia trachomatis infection and its sequelae pelvic inflammatory disease. BMC Infect Dis. 2015;15:233.CrossRefPubMedPubMedCentral Herzog SA, Low N, Berghold A. Sample size considerations using mathematical models: an example with Chlamydia trachomatis infection and its sequelae pelvic inflammatory disease. BMC Infect Dis. 2015;15:233.CrossRefPubMedPubMedCentral
39.
go back to reference Wu HL. Statistical methods for HIV dynamic studies in AIDS clinical trials. Stat Methods Med Res. 2005;14:171–92. Wu HL. Statistical methods for HIV dynamic studies in AIDS clinical trials. Stat Methods Med Res. 2005;14:171–92.
40.
go back to reference Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15:57.CrossRefPubMedPubMedCentral Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15:57.CrossRefPubMedPubMedCentral
41.
go back to reference Chen HH, Prevost TC, Duffy SW. Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models. Brit J Cancer. 1999;79:1894–900.CrossRefPubMedPubMedCentral Chen HH, Prevost TC, Duffy SW. Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models. Brit J Cancer. 1999;79:1894–900.CrossRefPubMedPubMedCentral
42.
go back to reference Longini IM, Hudgens MG, Halloran ME, Sagatelian KA. Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. Stat Med. 1999;18:53–68.CrossRefPubMed Longini IM, Hudgens MG, Halloran ME, Sagatelian KA. Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. Stat Med. 1999;18:53–68.CrossRefPubMed
43.
go back to reference Hoad KA, van't Hoog AH, Rosen D, Marston B, Nyabiage L, Williams BG, et al. Modelling local and global effects on the risk of contracting tuberculosis using stochastic Markov-chain models. Math Biosci. 2009;218:98–104.CrossRefPubMed Hoad KA, van't Hoog AH, Rosen D, Marston B, Nyabiage L, Williams BG, et al. Modelling local and global effects on the risk of contracting tuberculosis using stochastic Markov-chain models. Math Biosci. 2009;218:98–104.CrossRefPubMed
44.
go back to reference Tuite AR, Fisman DN. Spectrum bias and loss of statistical power in discordant couple studies of sexually transmitted infections. STD. 2011;38:50–6.CrossRef Tuite AR, Fisman DN. Spectrum bias and loss of statistical power in discordant couple studies of sexually transmitted infections. STD. 2011;38:50–6.CrossRef
46.
go back to reference Chan MS, Srividya A, Norman RA, Pani SP, Ramaiah KD, Vanamail P, et al. Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg. 1998;59:606–14.CrossRefPubMed Chan MS, Srividya A, Norman RA, Pani SP, Ramaiah KD, Vanamail P, et al. Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg. 1998;59:606–14.CrossRefPubMed
47.
go back to reference Cowled BD, Garner MG, Negus K, Ward MP. Controlling disease outbreaks in wildlife using limited culling: modelling classical swine fever incursions in wild pigs in Australia. Vet Res. 2012; doi: 10.1186/1297-9716-43-3. Cowled BD, Garner MG, Negus K, Ward MP. Controlling disease outbreaks in wildlife using limited culling: modelling classical swine fever incursions in wild pigs in Australia. Vet Res. 2012; doi: 10.​1186/​1297-9716-43-3.
52.
go back to reference Herzog SA, Heijne JCM, Althaus CL, Low N. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Sex Transm Dis. 2012;39:628–37. doi: 10.1097/OLQ.0b013e31825159ff.CrossRefPubMed Herzog SA, Heijne JCM, Althaus CL, Low N. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Sex Transm Dis. 2012;39:628–37. doi: 10.​1097/​OLQ.​0b013e31825159ff​.CrossRefPubMed
53.
go back to reference Boily MC, Mâsse BR, Desai K, Alary M, Anderson RM. Some important issues in the planning of phase III HIV vaccine efficacy trials. Vaccine. 1999;17:989–1004.CrossRefPubMed Boily MC, Mâsse BR, Desai K, Alary M, Anderson RM. Some important issues in the planning of phase III HIV vaccine efficacy trials. Vaccine. 1999;17:989–1004.CrossRefPubMed
Metadata
Title
Mathematical models used to inform study design or surveillance systems in infectious diseases: a systematic review
Authors
Sereina A. Herzog
Stéphanie Blaizot
Niel Hens
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2874-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.